MiMedx Announces Record Third Quarter Results
Published: Oct 30, 2013
MARIETTA, Ga., Oct. 30, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.
Highlights of third quarter of 2013 results include:
-- Revenue exceeds high end of guidance (8th consecutive quarter of meeting or exceeding upper end of guidance)
Help employers find you! Check out all the jobs and post your resume.